Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer | Zendy

Eun Kyung Jang | Zendy; Won Gu Kim | Zendy; Hyemi Kwon | Zendy; Yun Mi Choi | Zendy; Min Ji Jeon | Zendy; Tae Yong Kim | Zendy; Young Kee Shong | Zendy; Won Bae Kim | Zendy; Eui Young Kim | Zendy

Open Access

Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer

Author(s) -

Eun Kyung Jang,

Won Gu Kim,

Hyemi Kwon,

Yun Mi Choi,

Min Ji Jeon,

Tae Yong Kim,

Young Kee Shong,

Won Bae Kim,

Eui Young Kim

Publication year - 2015

Publication title -

european thyroid journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.23

H-Index - 10

eISSN - 2235-0802

pISSN - 2235-0640

DOI - 10.1159/000437365

Subject(s) - medicine , metformin , diabetes mellitus , thyroid cancer , body mass index , type 2 diabetes , oncology , cervical cancer , metastasis , thyroglobulin , cancer , glycated hemoglobin , gastroenterology , thyroid , endocrinology , insulin

Type 2 diabetes is known to increase the risk and progression of certain types of cancer. Metformin treatment of diabetic patients is reported to have beneficial effects on some cancers. We evaluated the clinical outcome of diabetic patients with differentiated thyroid cancer (DTC) according to metformin treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research